Literature DB >> 9115215

Synthesis of the mammalian telomere lagging strand in vitro.

P M Reveal1, K M Henkels, J J Turchi.   

Abstract

Using a synthetic telomere DNA template and whole cell extracts, we have identified proteins capable of synthesizing the telomere complementary strand. Synthesis of the complementary strand required a DNA template consisting of 10 repeats of the human telomeric sequence d(TTAGGG) and deoxy- and ribonucleosidetriphosphates and was inhibited by neutralizing antibodies to DNA polymerase alpha. No evidence for RNA-independent synthesis of the lagging strand was observed, suggesting that a stable DNA secondary structure capable of priming the lagging strand is unlikely. Purified DNA polymerase alpha/primase was capable of catalyzing synthesis of the lagging strand with the same requirements as those observed in crude cell extracts. A ladder of products was observed with an interval of six bases, suggesting a unique RNA priming site and site-specific pausing or dissociation of polymerase alpha on the d(TTAGGG)10 template. Removal of the RNA primers was observed upon the addition of purified RNase HI. By varying the input rNTP, the RNA priming site was determined to be opposite the 3' thymidine nucleotide generating a five-base RNA primer with the sequence 5'-AACCC. The addition of UTP did not increase the efficiency of priming and extension, suggesting that the five-base RNA primer is sufficient for extension with dNTPs by DNA polymerase alpha. This represents the first experimental evidence for RNA priming and DNA extension as the mechanism of mammalian telomeric lagging strand replication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115215     DOI: 10.1074/jbc.272.18.11678

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  In vitro reconstitution of the end replication problem.

Authors:  R Ohki; T Tsurimoto; F Ishikawa
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  In vitro expansion of mammalian telomere repeats by DNA polymerase alpha-primase.

Authors:  K Nozawa; M Suzuki; M Takemura; S Yoshida
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

3.  Telomere-bound TRF1 and TRF2 stall the replication fork at telomeric repeats.

Authors:  Rieko Ohki; Fuyuki Ishikawa
Journal:  Nucleic Acids Res       Date:  2004-03-08       Impact factor: 16.971

4.  Differences in telomere length between homologous chromosomes in humans.

Authors:  J A Londoño-Vallejo; H DerSarkissian; L Cazes; G Thomas
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

5.  DNA damage induced hyperphosphorylation of replication protein A. 2. Characterization of DNA binding activity, protein interactions, and activity in DNA replication and repair.

Authors:  Steve M Patrick; Greg G Oakley; Kathleen Dixon; John J Turchi
Journal:  Biochemistry       Date:  2005-06-14       Impact factor: 3.162

6.  Coordinate regulation of G- and C strand length during new telomere synthesis.

Authors:  X Fan; C M Price
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

7.  Human replication protein A unfolds telomeric G-quadruplexes.

Authors:  Tonatiuh Romero Salas; Irina Petruseva; Olga Lavrik; Anne Bourdoncle; Jean-Louis Mergny; Alain Favre; Carole Saintomé
Journal:  Nucleic Acids Res       Date:  2006-09-14       Impact factor: 16.971

8.  The CDC13-STN1-TEN1 complex stimulates Pol α activity by promoting RNA priming and primase-to-polymerase switch.

Authors:  Neal F Lue; Jamie Chan; Woodring E Wright; Jerard Hurwitz
Journal:  Nat Commun       Date:  2014-12-12       Impact factor: 14.919

9.  STN1-POLA2 interaction provides a basis for primase-pol α stimulation by human STN1.

Authors:  Swapna Ganduri; Neal F Lue
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

Review 10.  Ubiquitination and SUMOylation in Telomere Maintenance and Dysfunction.

Authors:  Zeliha Yalçin; Carolin Selenz; Jacqueline J L Jacobs
Journal:  Front Genet       Date:  2017-05-23       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.